Leridistim

DB15095InvestigationalProtein Based Therapies

Leridistim is under investigation in clinical trial NCT00004215 (Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia).

Mechanism: Pharmacologically active on Granulocyte colony-stimulating factor receptor and Interleukin-3 receptor subunit alpha
Curator reviewed

Resolves to

Compound

UNIIWYY7RA43DKCAS193700-51-5

Targets

Q99062CSF3RP26951IL3RA

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Leridistim, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account